Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Ayala Pharmaceuticals (AYLA) Short Interest Ratio & Short Volume

Ayala Pharmaceuticals logo

Ayala Pharmaceuticals Short Interest Data

Ayala Pharmaceuticals (AYLA) has a short interest of 48,200 shares, representing 0.45% of the float (the number of shares available for trading by the public). This marks a -34.86% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 76,300 shares to cover all short positions.

Current Short Interest
48,200 shares
Previous Short Interest
74,000 shares
Change Vs. Previous Month
-34.86%
Dollar Volume Sold Short
$19.28 thousand
Short Interest Ratio
0.6 Days to Cover
Last Record Date
December 30, 2022
Outstanding Shares
14,821,000 shares
Float Size
10,740,000 shares
Short Percent of Float
0.45%
Today's Trading Volume
0 shares
Average Trading Volume
76,300 shares
Today's Volume Vs. Average
0%
Short Selling Ayala Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AYLA Short Interest Over Time

AYLA Days to Cover Over Time

AYLA Percentage of Float Shorted Over Time

Ayala Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/30/202248,200 shares $19.28 thousand -34.9%0.5%0.6 $0.40
12/15/202274,000 shares $40.70 thousand -50.3%0.7%0.5 $0.55
11/30/2022148,800 shares $81.84 thousand -21.1%1.4%0.8 $0.55
11/15/2022188,500 shares $109.52 thousand -46.9%1.8%0.6 $0.58
10/31/2022354,900 shares $269.72 thousand +15.7%4.8%1.1 $0.76
10/15/2022306,700 shares $282.16 thousand -56.5%4.1%0.1 $0.92
9/30/2022705,400 shares $705.40 thousand +145.9%9.6%0.3 $1.00
9/15/2022286,900 shares $393.05 thousand +16.2%3.9%0.1 $1.37
8/31/2022246,900 shares $404.92 thousand +1,524.3%3.5%0.1 $1.64
8/15/202215,200 shares $19 thousand -98.0%0.2%0 $1.25
7/31/2022775,500 shares $1.33 million +2,459.4%11.6%0.3 $1.71
7/15/202230,300 shares $36.06 thousand -6.5%0.5%0.3 $1.19
6/30/202232,400 shares $35.32 thousand -27.8%0.5%0.6 $1.09
6/15/202244,900 shares $62.86 thousand -52.5%0.7%0.8 $1.40
5/31/202294,500 shares $167.27 thousand +1,650.0%1.4%1.7 $1.77
5/15/20225,400 shares $10.80 thousand -15.6%0.1%0.2 $2.00
4/30/20226,400 shares $16.13 thousand -63.6%0.1%0.3 $2.52
4/15/202217,600 shares $54.03 thousand +33.3%0.4%0.7 $3.07
3/31/202213,200 shares $52.54 thousand +428.0%0.3%0.5 $3.98
3/15/20222,500 shares $8.98 thousand -95.2%0.1%0.1 $3.59
2/28/202251,500 shares $204.46 thousand -0.6%1.1%1.7 $3.97
2/15/202251,800 shares $266.77 thousand -14.5%1.1%1.7 $5.15
1/31/202260,600 shares $344.21 thousand -4.9%1.3%1.8 $5.68
1/15/202263,700 shares $422.33 thousand +14.2%1.4%2 $6.63
12/31/202155,800 shares $474.86 thousand -30.4%1.4%2 $8.51
12/15/202180,200 shares $722.60 thousand -36.1%2.0%3.4 $9.01
11/30/2021125,500 shares $1.19 million +2.5%3.8%4 $9.50
11/15/2021122,500 shares $1.38 million -2.2%3.7%4.2 $11.25
10/29/2021125,200 shares $1.37 million -0.5%3.8%4.4 $10.98
10/15/2021125,800 shares $1.26 million +1.2%3.8%3.8 $10.00
9/30/2021124,300 shares $1.41 million -3.3%3.7%3.2 $11.34
9/15/2021128,600 shares $1.81 million +1.4%3.9%3.3 $14.09
8/31/2021126,800 shares $1.61 million -10.1%3.8%4.3 $12.67
8/13/2021141,000 shares $1.72 million +3.9%4.2%4.9 $12.21
7/30/2021135,700 shares $1.70 million -11.3%4.1%5.1 $12.50
7/15/2021153,000 shares $1.81 million +8.4%4.6%7.3 $11.86
6/30/2021141,100 shares $1.44 million -3.7%4.2%7.7 $10.19
6/15/2021146,500 shares $1.52 million +1.7%4.4%12.2 $10.35
5/28/2021144,000 shares $1.37 million +0.2%4.3%12.2 $9.54
5/14/2021143,700 shares $1.41 million -1.2%4.3%9.6 $9.80
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
4/30/2021145,500 shares $1.51 million -0.6%4.4%4.6 $10.40
4/15/2021146,300 shares $1.51 million +42.6%4.5%4.3 $10.29
3/31/2021102,600 shares $1.10 million -4.7%3.5%2.7 $10.73
3/15/2021107,600 shares $1.44 million +28.9%3.8%3.1 $13.42
2/26/202183,500 shares $1.44 million +71.1%2.9%2.4 $17.29
2/12/202148,800 shares $973.56 thousand -7.9%1.7%1.4 $19.95
1/29/202153,000 shares $685.29 thousand -16.5%1.8%3.1 $12.93
1/15/202163,500 shares $780.42 thousand No Change2.2%4.2 $12.29

AYLA Short Interest - Frequently Asked Questions

What is Ayala Pharmaceuticals' current short interest?

Short interest is the volume of Ayala Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 30th, investors have sold 48,200 shares of AYLA short. 0.45% of Ayala Pharmaceuticals' shares are currently sold short. Learn More on Ayala Pharmaceuticals' current short interest.

What is a good short interest ratio for Ayala Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AYLA shares currently have a short interest ratio of 1.0. Learn More on Ayala Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Ayala Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Ayala Pharmaceuticals' floating shares are currently sold short.

Is Ayala Pharmaceuticals' short interest increasing or decreasing?

Ayala Pharmaceuticals saw a decrease in short interest in the month of December. As of December 30th, there was short interest totaling 48,200 shares, a decrease of 34.9% from the previous total of 74,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ayala Pharmaceuticals' float size?

Ayala Pharmaceuticals currently has issued a total of 14,821,000 shares. Some of Ayala Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ayala Pharmaceuticals currently has a public float of 10,740,000 shares.

How does Ayala Pharmaceuticals' short interest compare to its competitors?

0.45% of Ayala Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ayala Pharmaceuticals: Cyclo Therapeutics, Inc. (3.55%), Finch Therapeutics Group, Inc. (0.10%), NKGen Biotech, Inc. (1.02%), AlloVir, Inc. (2.56%), Chromocell Therapeutics Co. (8.70%), Calidi Biotherapeutics, Inc. (1.23%), CEL-SCI Co. (5.24%), Omega Therapeutics, Inc. (26.99%), AIM ImmunoTech Inc. (414.92%), Fresh Tracks Therapeutics, Inc. (0.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($3.31 billion), T. Rowe Price Group, Inc. ($2.13 billion), TC Energy Corporation ($2.13 billion), Paramount Global ($1.50 billion), Coinbase Global, Inc. ($1.48 billion), Etsy, Inc. ($1.48 billion), Pacific Gas & Electric Co. ($1.47 billion), Old Dominion Freight Line, Inc. ($1.46 billion), United Rentals, Inc. ($1.35 billion), and Voya Financial, Inc. ($1.32 billion). View all of the most shorted stocks.

What does it mean to sell short Ayala Pharmaceuticals stock?

Short selling AYLA is an investing strategy that aims to generate trading profit from Ayala Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ayala Pharmaceuticals?

A short squeeze for Ayala Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AYLA, which in turn drives the price of the stock up even further.

How often is Ayala Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AYLA, twice per month. The most recent reporting period available is December, 30 2022.




This page (NASDAQ:AYLA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners